A Bayesian Joint Model of Longitudinal Kidney Disease Progression, Recurrent Cardiovascular Events, and Terminal Event in Patients with Chronic Kidney Disease
Related Posts
Naim MAAZ, Thomas F, Streja E, Davis RL, Kalantar-Zadeh K, Sumida K, Kovesdy CP. Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels[...]
Tuttle KR, Danovitch G. Reimagining Nephrology Training in a Cardiovascular-Kidney-Metabolic Framework. Clin J Am Soc Nephrol. 2026 Jul 1. doi: 10.2215/CJN.0000001132. Epub ahead of print.[...]
Burnett CT, Hughes A, Jaure A, Ju A, Guha C, Howell M, Manera K, Cheetham M, Wilkie M, Loud F, Figueiredo A, Cheung C, Schwartz[...]